Rapicut Carbides (500360)

Turnaround

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹146.15
Market Cap₹87.2 Cr
P/E Ratio47.36
ROCE-6.11%
ROE8.38%
Dividend Yield0%
Profit Growth197.52%
Debt/Equity
Sales Growth78.06%
52-Week Range₹66.66 — ₹204.95
SectorIndustrial Manufacturing
Book Value₹41.47

Strengths

Concerns

AI Analysis

Let me look at Rapicut Carbides the way Graham would: as a partial owner of a business, not a ticker. At ₹146.15, the market is asking ₹87 Cr for the whole company. That sounds small enough to be nimble, but small also means fragile. The recent numbers are eye-catching: sales grew 78.06%, and profit jumped 197.52%. The latest quarter shows ₹21 Cr in sales and ₹2 Cr net profit, so something positive is happening. But I have to weigh that against the quality of the franchise. A 47.36 P/E is steep for a business that only earns 8.38% on equity and, more troubling, -6.11% on capital employed. Negative ROCE means the core operations are not yet earning the cost of capital. There is no dividend to compensate patient shareholders, and promoter holding is not disclosed, so I cannot judge alignment. The 52-week range, from ₹66.66 to ₹204.95, tells me this is a volatile, cyclical sort of business, not a steady compounder. The F-score of 6 is mediocre, not a clean bill of health. PEG of 0.34 looks cheap only if this explosive growth continues for years; growth from a low base often does not. If I annualize the latest quarter, the stock might not be as expensive as the trailing P/E suggests, but one good quarter is not enough proof. Carbide tooling is a competitive industrial niche, and I see no durable moat in these numbers. This feels like a turnaround or cyclical recovery rather than a great company. In Buffett's words, it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. Here, I have a questionable company at a demanding price. I will watch, not buy.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer